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INTRODUCTION
Articular hyaline cartilage is a specialized connective tissue important for the distribution 
of  pressure and shear forces within joints with a specifi c role in animal locomotion 
*Corresponding author: e-mail: denisa.harvanova@upjs.sk
Research article
The topic of  the study was to verify in vivo survival of  in vitro cultured autologous and 
allogenous chondrocytes suspended in a fi brin glue Beriplast® or seeded on Collagen type 
I-Hyaluronan (Col type I-HYA) scaffolds for the regeneration of  articular cartilage defects 
in rabbits. The study was carried out on 15 domestic rabbits randomly assigned to fi ve 
groups (n = 3 in each) with different treatments of  artifi cially created chondral defects 
(ChD´s). These defects were made in a non-load-bearing area of  medial condyle of  the 
distal femur, and were treated as follows: 1st and 3rd group: the ChD´s were fi lled with 
autologous or allogenous chondrocytes seeded on Col type I-HYA scaffolds, respectively. 
The scaffolds were fi xed to the ChD´s by fi brin glue Beriplast®; 2nd and 4th group: the 
ChD´s were fi lled with a suspension of  autologous or allogenous chondrocytes in fi brin 
glue Beriplast®, respectively, and they were immediately covered by unseeded Col type 
I-HYA scaffolds; Control group: the ChD´s were left to heal spontaneously without any 
treatment. Macroscopical, histological and immunohistochemical analyses of  the ChD´s 
were performed 12 months after the treatment. In all treated groups, the chondrocytes 
were capable to proliferate and produce the cartilage extracellular matrix, including 
proteoglycans and type II collagen, as compared to the control “untreated” group. On the 
other hand, the production of  hyaline-like cartilage tissue confi rmed that both therapeutic 
methods using autologous chondrocytes can be applied successfully for the treatment of  
chondral defects in rabbits.
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[1]. Mature articular cartilage has a limited potential for the repair of  critical-sized 
defects because of  its avascularity and the absence of  stem cells [2]. The response 
of  the normal articular cartilage to damage or degeneration is frequently partial and 
repair of  the damaged tissue is incomplete. Surface defects of  articular cartilage do 
not heal spontaneously and usually turn to extensive degeneration [3]. It was observed 
that despite the limited ability of  chondrocytes to migrate from marginal zones into 
the defective site, they cannot multiply in these locations and produce macromolecules 
needed for the repair of  the organized intercellular matrix typical of  normal articular 
cartilage [4].
Cartilage properties result from its microscopic structure. Detailed studies of  morphology 
and biology of  mature cartilage showed that it is a highly organized structure. Complex 
connections between the chondrocytes and the matrix are maintained actively and 
are responsible for the preservation of  the shape and function of  the tissue owing 
to the structural character of  the solid component (e.g.: collagen, proteoglycans and 
glycoproteins). Therefore, the tissue that would reconstruct correctly the damaged 
surface of  the articular cartilage has to replicate these structures very precisely thus 
cartilaginous tissue defects could be repaired.
Current scientifi c trends present new possibilities for the repair of  cartilage defects. 
Transplantation of  autologous or allogenous chondrocytes, synovial mesenchymal stem 
cells, and biodegradable scaffolds are the methods that have been tested experimentally 
and clinically [5-11]. Implants seeded with chondrocytes cultured in vitro support the 
production of  the extracellular matrix by chondrocytes, mainly glycosaminoglycans 
and type II collagen [12,13]. The implantation of  chondrocyte–collagen composites 
into cartilage defects has proved a promising method of  cartilage repair [14,15] and 
numerous in vivo studies in animals have shown that hyaluronan-based scaffolds seeded 
with autologous chondrocytes are useful for inducing the formation of  hyaline-like 
cartilage tissue and are reabsorbed in the absence of  an infl ammatory response [16,17].
The aims of  our study were to investigate a repair process of  artifi cially created cartilage 
defects in rabbits treated by autologous and allogenous chondrocytes in a suspension 
in fi brin glue Beriplast® or seeded on Collagen type I-Hyaluronan (Col type I-HYA) 
scaffolds. Chondral defects (ChD´s) were created in such a manner as not to affect 
the zone of  calcifi ed cartilage in a non-load-bearing area of  the medial condyle of  the 
distal femur. The healing process of  ChD´s was evaluated macroscopically, as well as by 
histological and immunohistochemical analyses 12 months after the treatment. 
MATERIALS AND METHODS
Animal care
This study was performed at the University of  Veterinary Medicine Košice, Slovakia 
respecting the guidelines for animal experiments with the approval of  the Ethical 
Committee. This experiment was carried out on 15 domestic rabbits assigned to four 
treated groups and the untreated “control” group (n = 3 in each). Within four weeks, 
two surgical procedures were performed. In both cases, the rabbits were premedicated 
with an intramuscular injection of  1% ketamin hydrochloride (Narkamon inj. a.u.v., 
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Léčiva, CZ) and 2% xylasin hydrochloride (Rompun amp. a.u.v, Bayer, Turkey) at doses 
of  40 mg/kg BW and 4 mg/kg BW, respectively and anesthesia was maintained with 2.0 
% isofl urane at 2 l/min. constant oxygen fl ow. 
The fi rst surgery was performed on the knee joint of  the left hind leg to obtain articular 
cartilage from a non-weight bearing area of  the medial femur condyle. All samples 
of  articular cartilage were harvested for 4 weeks in vitro cultivation of  chondrocytes. 
One month after the fi rst surgery, on the same knee joint, circular chondral defects (3 
mm in diameter) were created artifi cially at the non-weight bearing area of  the medial 
femur condyle using a metal puncture needle (Chirana, SR) during arthrotomy of  the 
knee joint. The ChD´s were made of  a desirable size and shape. While creating the 
ChD´s, our aim was to prevent their penetration into the vascularized subchondral zone 
as the zone of  calcifi ed cartilage should remain intact, because deformations of  the 
vascularized layer are accompanied by a bloody discharge what induces an “undesired” 
non-specifi c healing process.  
One month after the fi rst surgical procedure, the second operation was performed 
under identical conditions, using the same procedure as described previously. The 
ChD´s created artifi cially during the fi rst surgery were treated as follows:
1st group: The ChD´s were fi lled with autologous chondrocytes seeded on Col type 
I-HYA scaffolds. The scaffolds were fi xed to the ChD´s by fi brin glue Beriplast® 
(Centeon Pharma GmbH). The scaffolds corresponded to the size, shape and 
depth of  the chondral defects, and they were implanted into the ChD´s in such 
a fashion that the surface seeded with cultured chondrocytes was directed into 
the defect base, while the surface without cultured chondrocytes was oriented 
to the synovial cavity of  the femur.
2nd group:  The ChD´s were fi lled with allogenous chondrocytes seeded on Col type 
I-HYA scaffolds. The same way as in Group 1 were used for  implantation of  
the scaffolds.
3rd group:  The ChD´s were fi lled with a suspension of  autologous chondrocytes in 
fi brin glue Beriplast® and they were immediately covered by Col type I-HYA 
scaffolds. 
4th group:  The ChD´s were fi lled with a suspension of  allogenous chondrocytes in 
fi brin glue Beriplast® and they were immediately covered by Col type I-HYA 
scaffolds.
Control group: The ChD´s were left to heal spontaneously without any treatment. 
Immediately after treatment, the knee joint was stabilized with a modifi ed Robert Jones 
bandage for 2 weeks. All rabbits were sacrifi ced by an intravenous injection of  veterinary 
euthanasia solution (T-61, Hoechst, Somerville, NJ) for the collection of  samples 12 
months after the treatment. 
Allogenous and autologous chondrocyte isolation and culture, and Col type 
I-HYA Scaffold preparation
Specifi c procedures for the isolation and cultivation of  chondrocytes and the preparation 
of  Col type I-HYA scaffolds were as described by Harvanova et al. [18]. Briefl y, circular 
fragments of  rabbit cartilage (3 mm in diameter) were digested by bacterial collagenase 
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type II (1mg/mL) (Gibco BRL®) in Nutrient mixture F-12 medium (Gibco BRL®) 
supplemented with 1% (v/v) antibiotic/antimycotic solution for 16-20 hours. The 
obtained chondrocytes were collected and cultivated in Nutrient mixture F-12 medium 
supplemented with 20% (v/v) fetal bovine serum (Gibco BRL®), 1% (v/v) insulin-
selenium-transferin A (Gibco BRL®), 1% (v/v) antibiotic/antimycotic solution at 
37°C in humidifi ed air with 5% CO2 for one month. Isolated chondrocyte cultures 
were passaged before confl uence was obtained with trypsin-EDTA (Gibco BRL®) and 
the medium was exchanged every three days. In the 3rd and 4th group, autologous and 
allogenous chondrocytes were used for the in vivo application with fi brin glue Beriplast® 
at density of  0.65-0.8 x 106 per ml and seeded on the Col type I-HYA scaffold, 
respectively. 
Enzymatically treated fi brous collagen type I (bovine Collagen type I from Achilles 
tendon, Hypro, Otrokovice, Czech Republic) was mixed with 0,5 M solution of  acetic 
acid and aqueous solution of  sodium hyaluronate (10mg/ml, 1500 kDa, CONTIPRO 
Ltd., Dolní Dobrouč, Czech Republic). Starch dialdehyde 2% (v/v) aqueous solution 
was added to the collagen/hyaluronan complex and homogenized in a blender at 1400 
RPM for 1 minute, pre-frozen for 12 hours and freeze dried (JOUAN LP3) at -45 °C, 
2x10-2 mBa for 6-8 hours. After lyophilisation, scaffolds were sealed in polyethylene 
bags and sterilized by 60Co radiation with a dose of  30 kGy. Lyophilized scaffolds were 
cut to a desired shape (3 mm in diameter) and were left in the culture medium for 1 
hour before in vitro cultivation. In the 1st and 2nd group, autologous and allogenous 
chondrocytes were seeded on the Col type I-HYA scaffold in at density of  0.47-0.6 
x 106 per cm2 and were cultured at 37°C in humidifi ed air with 5% CO2 for 4 weeks, 
respectively. The culture medium was exchanged every three days.
Locomotory activities
Evaluation was based on the time needed to full load limb recovery after treatment and 
on monitoring of  patella position, septic arthritis, production of  exudate compactness 
of  suture, and infection of  wounds which can also refl ect the status of  the defect repair.
Macroscopic evaluation 
The gross appearance of  the ChD´s was evaluated for color, integrity, contour and 
smoothness of  the surface. 
Histological and immunohistochemical analyses
The specimens of  treated medial condyles of  the distal femur in each rabbit were fi xed 
in 10 % phosphate-buffered formalin (Sigma-Aldrich®, Slovak Republic) for 48 h. 
Subsequently, they were washed in water and decalcifi ed in 25% Chelaton III (v/v) pH 
7.4 (Bioptika, Italy) at 37°C for 7 days. After decalcifi cation, the samples were washed 
in water for 24 h, embedded in paraffi n wax, and 15 μm thick slices were cut sagittally, 
and were stained in situ with Haemotoxylin-Eosin (H&E) and Safranine O (specifi c 
for proteoglycans). Immunohistochemical staining was carried out using antibodies 
against collagen type II fi bres (Rabbit Anti-Human Collagen type II, BIODESIGN 
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International, Saco, ME USA) and porcine immunoglobulin against human IgG tagged 
with fl orescein-isothiocyanate (SwAHu/IgG-FITC, SeVac, Prague, Czech Republic). 
Both antibodies were diluted 1:100 in 1% phosphate buffered saline (10 mM sodium 
phosphate, 0.15 M sodium chloride, pH 7.4). 
The evaluation was performed by light microscopy and fl uorescence microscopy 
using Olympus advanced inverted microscope IX-71 with an improved fl uorescence 
illuminator. The histological sections were examined for the quality of  the repair process 
and were graded with use of  histological scale described by [6]. All stained slides were 
evaluated in a blind test by three experienced histologists. 
RESULTS
Locomotory activities
Despite repeated arthrotomy, none of  the animals showed complications in relation 
to patella luxation, septic arthritis and excessive production of  exudate, dehiscence of  
sutures or secondary infection of  wounds. After the second operation, we observed 
that the rabbits spontaneously put less weight on the operated limb. The full load 
and extension of  the hind leg recovered completely at the end of  the 3rd week after 
treatment, it means, one week after the bandage removal. Moreover, pain as a factor 
which signifi cantly limits movements, is not expected in this type of  defect (partial 
cartilage loss) due to the avascular and aneural character of  the articular cartilage.
Macroscopic evaluation
The patellar joints were fi lled with a clear viscous synovial fl uid in all rabbits. In all 
treated groups, neither detachment of  the Col type I-HYA scaffolds (except for a 
severally irregular surface of  the treated ChD in one rabbit in the 4th group) nor signs 
of  articular surface damage (such as chondromalacia, osteoarthritis or synovitis) or 
hypertrophy were found. In the 1st and 3rd group treated by the autologous or allogenous 
chondrocytes, respectively, the ChD´s have been fi lled with smooth cartilaginous tissue 
of  a color similar to healthy cartilage (Fig. 1a). The ChD´s were completely fi lled in 3 
rabbits (one in the 1st group and two in the 3rd group), but one edge of  the scaffolds was 
not completely integrated with the ChD´s in the other rabbits. On the other hand, in the 
2nd and 4th group treated with the suspension of  autologous or allogenous chondrocytes, 
respectively, we have found just partial healing of  the ChD´s in all rabbits (Fig. 1b). In 
the control group, no signs of  cartilage reparation processes were observed and the 
ChD´s retained sharp edges even 12 months after surgery (Fig. 1c). Surprisingly, in 
the rabbit no. 15, the ChD was covered with a whitish tissue that did not resemble the 
cartilage tissue. 
Histological and immunohistochemical analyses
Results of  the histological examination of  all stained slides are presented in Table 1. 
In the 1st group, the ChD´s were fi lled with a hyaline-like cartilage tissue (HyLCa) (Fig. 
2a), but the intensity of  Safranin O staining was high in all layers (deep, middle and 
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surface layer) of  the ChD (Fig. 2b) only in rabbit no. 3. Except for HyLCa, we have also 
observed sporadic segments of  fi brocartilage (FiCa), particularly in the surface layer of  
the ChD´s in rabbit no. 1 and no. 2 from the same group. Safranin O staining revealed 
a relatively high production of  proteoglycans (PG´s) and collagen type II fi bres, in the 
deep layer, but lower intensity of  staining has been exhibited in the surface layer of  
the ChD´s. Chondrocytes in the deep layer have a round shape and their density was 
higher as compared to the surface layer of  the ChD´s. Immunohistochemical staining 
confi rmed the presence of  cells with the chondrocyte phenotype in all ChD´s (Fig. 2c). 
In rabbit no. 1, a slight hypertrophy of  HyLCa was detected probably due to the shape 
of  the scaffold which could be not completely suitable for the insertion into the defect. 
All in all, a local infl ammatory reaction was not observed in all cases.  
In the 2nd group, apparently lower numbers of  cells with the chondrocyte phenotype 
occupied the ChD´s (Fig. 3a), as well as decreased production of  PG´s (Fig. 3b) and 
collagen type II fi bers (Fig. 3c) were found than in the 1st group. In addition, the 
ChD´s healed with both types of  cartilage tissues, but predominantly by FiCa. A local 
Figure 2. Histological and immunohistochemical analyses of  the chondral defects repaired by 
autologous chondrocyte seeded on Col type I-HYA scaffold (1st group) a) H&E staining, 150x 
magnifi cation b) Safranin O staining, 100x magnifi cation, arrow shows a weakened adhesion of  
the autologous chondrocyte seeded on Col type I-HYA scaffold to the native chondral cartilage 
c) Immunohistochemical staining, 200x magnifi cation. (HyLCa = hyaline-like cartilage tissue, 1–
native chondral cartilage, 2–autologous chondrocytes seeded on Col type I-HYA scaffold)
Figure 1. Macroscopic view of  the chondral defects repaired a) by autologous chondrocyte 
seeded on Col type I-HYA scaffold (1st group), b) by suspension of  allogenous chondrocytes 
in a fi brin glue (4th group) c) without any treatment (Control group). Arrows show the position 
of  the chondral defects.
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infl ammatory reaction was not confi rmed by histological analysis, what indicates that 
the allogenous chondrocytes did not cause the scaffold rejection accompanied by its 
lacked mechanical stability in the defect leading to infl ammation.   
In the 3rd group, the ChD´s were fi lled completely with HyLCa in two rabbits (no. 8 and 
no. 9). In the deep layer of  the ChD´s, the cells resembling chondrocytes of  the native 
cartilage tissue have a round shape (Fig. 4a, 4b). The surface layer of  the ChD´s showed 
the presence of  collagen type II fi bers produced by chondrocytes seeded on Col type 
I-HYA scaffold as in the 1st group. The intensity of  PG´s was low in the surface layer, 
particularly at the edges of  the ChD´s, but in the middle and deep layer were higher (Fig. 
4c, 4d). Immunohistochemical staining proved the presence of  a cellular population of  
the chondrocyte phenotype in the ChD´s (Fig. 4e). 
In the 4th group, we have observed only partial regeneration of  the ChD´s in two rabbits 
(no. 10 and no. 12). A severely irregular surface of  the treated ChD was found in the 
rabbit no. 11. Reparation of  the ChD´s was incomplete and damage was located mostly 
at the edges of  the defects. HyLCa has been observed in the middle and deep layer of  
the defects, but the periphery of  the ChD´s was fi lled with FiCa. The production of  
PG´s and the density of  cells with the chondrocyte phenotype were low. Fibrin glue 
components without the cell population were seen in these ChD´s, too. 
Category
Points 1st group 2nd group 3rd group 4th group Control 
group
Number of  rabbit 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Cell morphology
Hyaline cartilage 0 0 0 0
Mostly hyaline 
cartilage 1 1 1 1
Mostly fi brocartilage 2 2 2 2 2 2 2 2
Mostly non-cartilage 3
Non-cartilage 4 4 4
Matrix staining (metachromatic)
Normal 0 0 0 0
Slighty reduced 1 1 1 1
Markedly reduced 2 2 2 2 2 2 2
No metachromatic 
staining 3 3 3 3
Surface regularity
Smooth ( 3/4) 0 0 0 0 0 0
Moderate ( 1/2-3/4) 1 1 1
Irregular (1/4-1/2) 2 2 2 2 2
Severely irregular 3 3 3 3 3
Thickness of  cartilage
 2/3 0 0 0 0
1/3-2/3 1 1 1 1 1 1 1 1 1 1 1
 1/3 2 2 2
Integration of  donor with host adjacent cartilage
Both edges integrated 0 0 0 0 0
One edge integrated 1 1 1 1 1 1 1 1 1 1
Neither edge 
integrated 2 2 2
Total maximum 14 4 4 0 8 8 7 4 0 0 8 9 8 14 14 10
Table 1. Histological grading scale for the repair of  the chondral defects in individual rabbits.
Acta Veterinaria-Beograd 2014, 64 (1), 61-72
68
In the control group, the ChD´s were left to heal spontaneously. The defects were empty 
in 2 rabbits (no. 13 and no. 14). In the rabbit no. 15, non-specifi c repair mechanisms 
were observed in the deep layer of  the ChD by the formation of  FiCa. Neither the 
production of  PG´s nor collagen type II fi bers were found in this group. 
Figure 3. Histological and immunohistochemical analyses of  the chondral defects repaired by 
allogenous chondrocyte seeded on Col type I-HYA scaffold (2nd group) a) H&E staining, 150x 
magnifi cation, b) Safranin O staining, 100x magnifi cation, very low production of  PG´s. c) Im-
munohistochemical staining, 100x magnifi cation, production of  collagen type II localised mainly 
in deep layer of  the chondral defect. (PG´s = proteoglycans, 1–native chondral cartilage, 2–al-
logenous chondrocytes seeded on Col type I-HYA scaffold, 3 – subchondral bone)
Figure 4. Histological and immunohistochemical analyses of  the chondral defects repaired by 
a  suspension of  autologous chondrocytes in fi brin glue (3rd group) a) H&E staining, 100x 
magnifi cation b) H&E staining, 150x magnifi cation, c) Safranin O stain, magnifi cation 100x, 
surface layer created by collagen type I fi bres from the scaffold, and marginal zone of  the chon-
dral defect with a low production of  PG´s, and deep layer of  the defect is repaired by HyLCa 
d) Safranin O stain, magnifi cation 150x, deep and middle layer of  the chondral defect with high 
production of  PG´s d) Immunohistochemical staining, 150x magnifi cation. (HyLCa = hyaline-
like cartilage tissue, PG´s = proteoglycans, 1 – surface layer of  the chondral defect, 2 – deep 
layer of  the condral defect, 3 – deep layer of  the native chondral cartilage, 4 – subchondral bone, 




In the last few years, a great effort was made to defi ne a suitable method for the implantation 
of  chondrocytes into the defective cartilage in order to support the regeneration of  
cartilage tissue. Studies comparing methods for cartilage tissue reconstruction using 
autologous chondrocytes, as well as allogenous chondrocytes are lacking. Therefore, we 
have decided to use two different methods of  implantation of  autologous and allogenous 
chondrocytes into the ChD´s: (a) a suspension of  chondrocytes in a fi brin glue covered 
by the Col type I-HYA scaffolds, and (b) chondrocytes seeded on the Col type I-HYA 
scaffolds fi xed with a fi brin glue. In addition, Lee et al. [19] found that chondrocytes 
cultured for 4 weeks are able to produce higher amounts of  hyaline cartilage after their 
implantation into chondral defects than these cultured for a signifi cantly shorter time 
(only 12h). Therefore, the culturing period of  chondrocytes for one month was chosen 
in our study. 
Different scaffolds were used as cell or tissue carriers for cartilage tissue engineering 
so far [20-23]. The major advantage of  collagen scaffolds, which were used in our 
experiment, is their tissue abundance and a highly organized structure. It is known, 
that porous three-dimensional structures consisting of  collagen fi bers support the 
viability of  chondrocytes and their production of  extracellular matrix in vitro. Collagen 
contains cell-adhesion domain sequences that induce specifi c cellular interactions [24]. 
Substrate-bonded hyaluronan exhibits size-dependent stimulation of  chondrogenic 
differentiation and also improves the proliferative activity of  cultured chondrocytes 
[25]. As previously published [26-28], small amounts of  hyaluronan (2% w/w) in three-
dimensional collagen scaffolds can enhance chondrogenesis. Based on our previous 
study [18], we can corroborate that the Col type I-HYA scaffolds had not any adverse 
effects on chondrocyte viability, morphology and phenotype during long term (2-3 
months) in vitro cultivation. Moreover, Lin et al. [23] found that chondrocytes seeded 
on Hyaluronan/Collagen II microspheres could exhibit a high activity in repairing a 
cartilage defect, what is in accordance with our fi ndings. 
On the other hand, suspension with chondrocytes can be injected with ease to the 
defect or target site. Defects orientated downwards are infl uenced by the gravitational 
forces which can affect the initial distribution of  transplantated chondrocytes and may 
have an important role in the fi nal clinical outcome [29]. This phenomenon was not 
observed in our study, but the partial detachment of  the Col type I-HYA scaffold was 
found in one rabbit treated with the suspension of  allogenous chondrocytes in fi brin 
glue. By our opinion, adhesive properties of  the fi brin glue could be altered due to its 
dilution with a medium of  cultured chondrocytes. All in all, comparing autologous vs. 
allogenous chondrocyte application, better proliferation of  cells with the chondrocyte 
fenotype and production of  PG´s, as well as the creation of  HyLCa were observed 
in both groups treated with autologous chondrocytes. Hong et al. [30] hypothesized 
that autologous structures have better biocompatibility with native tissues, which was 
corroborated with our fi ndings too.
As a limitation of  this study can be considered that, a small number of  experimental 
animals (only 3 rabbits per group) was used. This discouraged the use of  statistical 
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analysis within the groups thus individual examination was chosen to present our 
fi ndings instead. Moreover, rabbits are not an optimal animal model for the evaluation 
of  the ChD´s due to the relatively small dimensions of  the knee joint and a thin layer 
of  chondrium, which is not thicker than 1 mm. 
In all treated groups, the chondrocytes were capable to proliferate and produce the 
cartilage extracellular matrix, including proteoglycans and type II collagen fi bers, as 
compared to the control “untreated” group. The fi brin glue ensured a suffi cient fi xation 
of  the scaffolds when it was applied undiluted, but its fi xative properties could be 
altered by a medium of  chondrocytes added thus further investigations with a higher 
number of  animals involved are required. For this reason, it can be concluded that the 
autologous chondrocytes seeded on a Collagen type I-Hyaluronan scaffold represents a 
very successful way of  treatment of  articular cartilage defects in rabbits. 
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REPARACIJA DEFEKATA HRSKAVICE KUNIĆA AUTOLOGNIM 
I ALOGENIM HONDROCITIMA ZASEJANIM NA KOLAGEN/
HIJALURONAN OSNOVU ILI SUSPENDOVANIM U FIBRINSKOM 
LEPKU
HORŇÁK Slavomír, HARVANOVÁ Denisa, LEDECKÝ Valent, HLUCHÝ Marian, 
VALENČÁKOVÁ-AGYAGOSOVÁ Alexandra, AMRICHOVÁ Judita, ROSOCHA 
Ján2, VAŠKO Gabriel, ŠVIHLA Róbert, PETROVIČ Vladimír
Cilj studije je bio da se verifi kuje in vivo preživljavanje in vitro kultivisanih autolognih i 
alogenih hondrocita suspendovanih u fi brinski Beriplast® lepak ili na kolagen Hyaluronan 
tip I (Col type I-HYA) osnovu radi regeneracije oštećenja zglobne hrskavice kod kunića. 
Ispitivanje je obavljeno na 15 domaćih kunića, odabranih slučajnim izborom koji su 
podeljeni u pet grupa (3 po grupi) kod kojih su veštački izazvana oštećenja hrskavice 
(ChD), tretirana na različite načine. Oštećenja su napravljena na površinama koje nisu 
noseće na medijalnom kondilusu distalnog femura, a tretman je podrazumevao: prva i 
treća grupa: ChD su punjene sa autolognim ili alogenim hondrocitima zasejanim na Col 
tip I-HYA osnovu. Osnove su fi ksirane na ChD pomoću fi brinskog lepka Beriplast®; 
druga i četvrta grupa: oštećenja su punjena suspenzijom autolognih ili alogenih hondrocita 
u fi brinskom Beriplast® lepku, a neposredno posle toga, prekriveni su sa nezasejanom 
Col tip I-HYA osnovom; kontrolna grupa: oštećenja su ostavljena da spontano zarastu, 
bez tretmana. Dvanaest meseci posle tretmana obavljene su makroskopske, histološke 
i imunohistološke analize promena. Kod svih životinja tretiranih grupa, hondrociti su 
bili sposobni da proliferišu i proizvode ekstracelularni matriks hrskavice, uključujući 
proteoglikane i II tip kolagena u poređenju sa kontrolnom “netretriranom” grupom. 
Sa druge strane, proizvodnja hrskavičavog tkiva nalik na hijalin potvrđuje da se oba 
terapijska metoda koji koriste autologne hondrocite mogu da uspešno primene u 
tretiranju defekata hrskavice kod kunića. 
